Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Otorhinolaryngology

  Free Subscription


Articles published in Head Neck

Retrieve available abstracts of 292 articles:
HTML format
Text format



Single Articles


    July 2018
  1. HONG YT, Hong KH
    Identification of lymphatic channels in the tracheoesophageal groove during central neck dissection for thyroid cancer.
    Head Neck. 2018 Jul 26. doi: 10.1002/hed.25125.
    PubMed     Text format     Abstract available


    June 2018
  2. MARIONI G, Cappellesso R, Ottaviano G, Fasanaro E, et al
    Nuclear nonmetastatic protein 23-H1 expression and epithelial-mesenchymal transition in laryngeal carcinoma: A pilot investigation.
    Head Neck. 2018 Jun 28. doi: 10.1002/hed.25188.
    PubMed     Text format     Abstract available


  3. LEBO NL, Griffiths R, Hall S, Dimitroulakos J, et al
    Effect of statin use on oncologic outcomes in head and neck squamous cell carcinoma.
    Head Neck. 2018 Jun 22. doi: 10.1002/hed.25152.
    PubMed     Text format     Abstract available


  4. OOFT ML, van Ipenburg J, van de Loo RJM, de Jong R, et al
    Differences in cancer gene copy number alterations between Epstein-Barr virus-positive and Epstein-Barr virus-negative nasopharyngeal carcinoma.
    Head Neck. 2018 Jun 21. doi: 10.1002/hed.25195.
    PubMed     Text format     Abstract available


    May 2018
  5. THAM T, Bardash Y, Herman SW, Costantino PD, et al
    Neutrophil-to-lymphocyte ratio as a prognostic indicator in head and neck cancer: A systematic review and meta-analysis.
    Head Neck. 2018 May 14. doi: 10.1002/hed.25324.
    PubMed     Text format     Abstract available


  6. WU JS, Tsai YC, Jian JJ, Chen HH, et al
    Survival without adjuvant chemotherapy for selected patients with stage II and III nasopharyngeal carcinoma after concurrent chemoradiotherapy alone.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25205.
    PubMed     Text format     Abstract available


  7. LANDEEN KC, Spanos WC, Gromer L
    Topical superoxide dismutase in posttreatment fibrosis in patients with head and neck cancer.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25119.
    PubMed     Text format     Abstract available


  8. ANDERSON NJ, Jackson JE, Smith JG, Wada M, et al
    Pretreatment risk stratification of feeding tube use in patients treated with intensity-modulated radiotherapy for head and neck cancer.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25316.
    PubMed     Text format     Abstract available


  9. TRIVEDI NP
    Oral cancer involving masticator space (T4b): Review of literature and future directions.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25211.
    PubMed     Text format     Abstract available


  10. SUCCO G, Crosetti E, Bertolin A, Piazza C, et al
    Treatment for T3 to T4a laryngeal cancer by open partial horizontal laryngectomies: Prognostic impact of different pathologic tumor subcategories.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25176.
    PubMed     Text format     Abstract available


  11. ALAHMAD YM, Aljaber M, Saleh AI, Yalcin HC, et al
    Effect of cell-phone radiofrequency on angiogenesis and cell invasion in human head and neck cancer cells.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25210.
    PubMed     Text format     Abstract available


  12. SONG JSA, Moolman N, Burrell S, Rajaraman M, et al
    Use of radioiodine-131 scan to measure influence of surgical discipline, practice, and volume on residual thyroid tissue after total thyroidectomy for differentiated thyroid carcinoma.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25204.
    PubMed     Text format     Abstract available


  13. MULCAHY CF, Mohamed ASR, Kanwar A, Hutcheson KA, et al
    Age-adjusted comorbidity and survival in locally advanced laryngeal cancer.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25200.
    PubMed     Text format     Abstract available


  14. ONO T, Azuma K, Kawahara A, Sasada T, et al
    Prognostic stratification of patients with nasopharyngeal carcinoma based on tumor immune microenvironment.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25189.
    PubMed     Text format     Abstract available


    April 2018
  15. NAIR D, Mair M, Singhvi H, Mishra A, et al
    Perineural invasion: Independent prognostic factor in oral cancer that warrants adjuvant treatment.
    Head Neck. 2018 Apr 29. doi: 10.1002/hed.25170.
    PubMed     Text format     Abstract available


  16. HO JC, Phan J
    Reirradiation of head and neck cancer using modern highly conformal techniques.
    Head Neck. 2018 Apr 23. doi: 10.1002/hed.25180.
    PubMed     Text format     Abstract available


  17. BERNSTEIN LJ, Pond GR, Gan HK, Tirona K, et al
    Pretreatment neurocognitive function and self-reported symptoms in patients with newly diagnosed head and neck cancer compared with noncancer cohort.
    Head Neck. 2018 Apr 17. doi: 10.1002/hed.25198.
    PubMed     Text format     Abstract available


  18. FAN CY, Jen YM, Su YC, Chao HL, et al
    Association between nasopharyngeal carcinoma and risk of optic neuropathy: A population-based cohort study.
    Head Neck. 2018 Apr 16. doi: 10.1002/hed.25177.
    PubMed     Text format     Abstract available


    March 2018
  19. SHINGLER E, Robles LA, Perry R, Penfold C, et al
    Systematic review evaluating randomized controlled trials of smoking and alcohol cessation interventions in people with head and neck cancer and oral dysplasia.
    Head Neck. 2018 Mar 30. doi: 10.1002/hed.25138.
    PubMed     Text format     Abstract available


  20. HAQUE SU, Niu L, Kuhnell D, Hendershot J, et al
    Differential expression and prognostic value of long non-coding RNA in HPV-negative head and neck squamous cell carcinoma.
    Head Neck. 2018 Mar 25. doi: 10.1002/hed.25136.
    PubMed     Text format     Abstract available


  21. HEGDE JV, Demanes DJ, Veruttipong D, Chin RK, et al
    Head and neck cancer reirradiation with interstitial high-dose-rate brachytherapy.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25137.
    PubMed     Text format     Abstract available


  22. KIM HK, Lee I, Lee J, Chang HS, et al
    BRAF(wild) papillary thyroid carcinoma has two distinct mRNA expression patterns with different clinical behaviors.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25151.
    PubMed     Text format     Abstract available


  23. RHOTEN BA, Murphy BA, Dietrich MS, Ridner SH, et al
    Depressive symptoms, social anxiety, and perceived neck function in patients with head and neck cancer.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25129.
    PubMed     Text format     Abstract available


  24. LUCIONI M, Lionello M, Salis G, Bertolin A, et al
    Bocca's hemipharyngo-total laryngectomy for hypopharyngeal carcinoma to avoid reconstruction with a pedicled flap.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25124.
    PubMed     Text format     Abstract available


  25. CONDELLO V, Macerola E, Ugolini C, De Napoli L, et al
    Analysis of circulating tumor DNA does not improve the clinical management of patients with locally advanced and metastatic papillary thyroid carcinoma.
    Head Neck. 2018 Mar 22. doi: 10.1002/hed.25155.
    PubMed     Text format     Abstract available


  26. MCEWEN SE, Dunphy C, Rios JN, Davis AM, et al
    Evaluation of a rehabilitation planning consult for survivors of head and neck cancer.
    Head Neck. 2018 Mar 22. doi: 10.1002/hed.25113.
    PubMed     Text format     Abstract available


  27. PAYNE K, Spruce R, Beggs A, Sharma N, et al
    Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma.
    Head Neck. 2018 Mar 15. doi: 10.1002/hed.25140.
    PubMed     Text format     Abstract available


  28. WANG CI, Yu CJ, Huang Y, Yi JS, et al
    Association of overexpressed karyopherin alpha 2 with poor survival and its contribution to interleukin-1beta-induced matrix metalloproteinase expression in oral cancer.
    Head Neck. 2018 Mar 15. doi: 10.1002/hed.25145.
    PubMed     Text format     Abstract available


  29. KIM H, Vargo JA, Beriwal S, Clump DA, et al
    Cost-effectiveness analysis of salvage therapies in locoregional previously irradiated head and neck cancer.
    Head Neck. 2018 Mar 14. doi: 10.1002/hed.25142.
    PubMed     Text format     Abstract available


  30. SUZUKI S, Yasunaga H, Matsui H, Fushimi K, et al
    Postoperative mechanical bowel obstruction after pharyngolaryngectomy for hypopharyngeal cancer: Retrospective analysis using a Japanese inpatient database.
    Head Neck. 2018 Mar 14. doi: 10.1002/hed.25139.
    PubMed     Text format     Abstract available


  31. YU F, Lu Y, Petersson F, Wang DY, et al
    Presence of lytic Epstein-Barr virus infection in nasopharyngeal carcinoma.
    Head Neck. 2018 Mar 9. doi: 10.1002/hed.25131.
    PubMed     Text format     Abstract available


  32. DAHER T, Tur MK, Brobeil A, Etschmann B, et al
    Combined human papillomavirus typing and TP53 mutation analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.
    Head Neck. 2018 Mar 9. doi: 10.1002/hed.25041.
    PubMed     Text format     Abstract available


  33. WANG X, Li Y, Gao Y, Ouyang D, et al
    Second primary squamous cell carcinoma in patients with nasopharyngeal carcinoma after radiotherapy predictors and prognostic factors.
    Head Neck. 2018 Mar 9. doi: 10.1002/hed.25130.
    PubMed     Text format     Abstract available


  34. MIZUSHIMA T, Ohnishi S, Shimizu Y, Hatanaka Y, et al
    Rapid detection of superficial head and neck squamous cell carcinoma by topically spraying fluorescent probe targeting dipeptidyl peptidase-IV.
    Head Neck. 2018 Mar 6. doi: 10.1002/hed.25126.
    PubMed     Text format     Abstract available


  35. VUONG HG, Odate T, Duong UNP, Mochizuki K, et al
    Prognostic importance of solid variant papillary thyroid carcinoma: A systematic review and meta-analysis.
    Head Neck. 2018 Mar 6. doi: 10.1002/hed.25123.
    PubMed     Text format     Abstract available


  36. LU J, Chen XM, Huang HR, Zhao FP, et al
    Detailed analysis of inflammatory cell infiltration and the prognostic impact on nasopharyngeal carcinoma.
    Head Neck. 2018 Mar 1. doi: 10.1002/hed.25104.
    PubMed     Text format     Abstract available


    February 2018
  37. PENFOLD CM, Thomas SJ, Waylen A, Ness AR, et al
    Change in alcohol and tobacco consumption after a diagnosis of head and neck cancer: Findings from head and neck 5000.
    Head Neck. 2018 Feb 27. doi: 10.1002/hed.25116.
    PubMed     Text format     Abstract available


  38. HAMSTRA DA, Lee KC, Eisbruch A, Sunkara P, et al
    Double-blind placebo-controlled multicenter phase II trial to evaluate D-methionine in preventing/reducing oral mucositis induced by radiation and chemotherapy for head and neck cancer.
    Head Neck. 2018 Feb 23. doi: 10.1002/hed.25115.
    PubMed     Text format     Abstract available


  39. DANILOVIC DLS, de Mello ES, Frazzato EST, Wakamatsu A, et al
    Oncogenic mutations in KEAP1 disturbing inhibitory Nrf2-Keap1 interaction: Activation of antioxidative pathway in papillary thyroid carcinoma.
    Head Neck. 2018 Feb 22. doi: 10.1002/hed.25105.
    PubMed     Text format     Abstract available


  40. MORISADA M, Chamberlin M, Allen C
    Exploring the rationale for combining ionizing radiation and immune checkpoint blockade in head and neck cancer.
    Head Neck. 2018 Feb 20. doi: 10.1002/hed.25101.
    PubMed     Text format     Abstract available


  41. OSBORN VW, Givi B, Rineer J, Roden D, et al
    Patterns of care and outcomes of adjuvant therapy for high-risk head and neck cancer after surgery.
    Head Neck. 2018 Feb 16. doi: 10.1002/hed.25103.
    PubMed     Text format     Abstract available


  42. CHAN SL, Ng LS, Goh X, Siow CH, et al
    Time course and clinical characterization of cisplatin-induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population.
    Head Neck. 2018 Feb 16. doi: 10.1002/hed.25112.
    PubMed     Text format     Abstract available


  43. GINGERICH MA, Smith JD, Michmerhuizen NL, Ludwig M, et al
    Comprehensive review of genetic factors contributing to head and neck squamous cell carcinoma development in low-risk, nontraditional patients.
    Head Neck. 2018 Feb 10. doi: 10.1002/hed.25057.
    PubMed     Text format     Abstract available


  44. YOSHIDA EJ, Luu M, David JM, Kim S, et al
    Postoperative chemoradiotherapy in patients with head and neck cancer aged 70 or older with positive margins or extranodal extension and the influence of nodal classification.
    Head Neck. 2018 Feb 8. doi: 10.1002/hed.25100.
    PubMed     Text format     Abstract available


  45. KIRKE DN, Qureshi MM, Kamran SC, Ezzat W, et al
    Role of adjuvant chemoradiotherapy in T4N0 stage IV head and neck cancer: A National Cancer Database analysis.
    Head Neck. 2018 Feb 8. doi: 10.1002/hed.25087.
    PubMed     Text format     Abstract available


  46. MURTHY SP, Balasubramanian D, Subramaniam N, Nair G, et al
    Prevalence of adverse pathological features in 1 to 4 cm low-risk differentiated thyroid carcinoma.
    Head Neck. 2018 Feb 8. doi: 10.1002/hed.25099.
    PubMed     Text format     Abstract available


  47. HALL SF, Griffiths RJ
    Evaluation of treatment outcomes in patients with supraglottic laryngeal cancer in Ontario, Canada: A population-based study.
    Head Neck. 2018 Feb 7. doi: 10.1002/hed.25073.
    PubMed     Text format     Abstract available


  48. BACK LJJ, Aro K, Tapiovaara L, Vikatmaa P, et al
    Sacrifice and extracranial reconstruction of the common or internal carotid artery in advanced head and neck carcinoma: Review and meta-analysis.
    Head Neck. 2018 Feb 5. doi: 10.1002/hed.25093.
    PubMed     Text format     Abstract available


  49. GUTTMANN DM, Kobie J, Grover S, Lin A, et al
    National disparities in treatment package time for resected locally advanced head and neck cancer and impact on overall survival.
    Head Neck. 2018 Feb 2. doi: 10.1002/hed.25091.
    PubMed     Text format     Abstract available


  50. TALMI YP, Takes RP, Alon EE, Nixon IJ, et al
    Prognostic value of lymph node ratio in head and neck squamous cell carcinoma.
    Head Neck. 2018 Feb 2. doi: 10.1002/hed.25080.
    PubMed     Text format     Abstract available


  51. LIN PJ, Twu CW, Liu YC, Lin TY, et al
    Comparison the clinical outcomes with altered versus conventional fractionated radiotherapy plus concurrent chemotherapy for advanced nasopharyngeal carcinoma.
    Head Neck. 2018 Feb 1. doi: 10.1002/hed.25084.
    PubMed     Text format     Abstract available


  52. TIRELLI G, Bergamini PR, Scardoni A, Gatto A, et al
    Intraoperative monitoring of marginal mandibular nerve during neck dissection.
    Head Neck. 2018 Feb 1. doi: 10.1002/hed.25078.
    PubMed     Text format     Abstract available


    January 2018
  53. VALLS-MATEUS M, Nogues-Sabate A, Blanch JL, Bernal-Sprekelsen M, et al
    Narrow band imaging for head and neck malignancies: Lessons learned from mistakes.
    Head Neck. 2018 Jan 31. doi: 10.1002/hed.25088.
    PubMed     Text format     Abstract available


  54. NAKAYAMA M, Gosho M, Hirose Y, Nishimura B, et al
    Modified combination of platelet count and neutrophil "to" lymphocyte ratio as a prognostic factor in patients with advanced head and neck cancer.
    Head Neck. 2018 Jan 31. doi: 10.1002/hed.25085.
    PubMed     Text format     Abstract available


  55. ZENGA J, Pipkorn P, Graboyes EM, Martin EJ, et al
    Oncologic outcomes of extended neck dissections in human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Head Neck. 2018 Jan 29. doi: 10.1002/hed.25060.
    PubMed     Text format     Abstract available


  56. AEBERHARD C, Mayer C, Meyer S, Mueller SA, et al
    Effect of preoperative immunonutrition on postoperative short-term outcomes of patients with head and neck squamous cell carcinoma.
    Head Neck. 2018 Jan 24. doi: 10.1002/hed.25072.
    PubMed     Text format     Abstract available


  57. VASAN K, Low TH, Gupta R, Ashford B, et al
    Lymph node ratio as a prognostic factor in metastatic cutaneous head and neck squamous cell carcinoma.
    Head Neck. 2018 Jan 23. doi: 10.1002/hed.25066.
    PubMed     Text format     Abstract available


  58. LAM JKS, Sundaresan P, Gebski V, Veness MJ, et al
    Immunocompromised patients with metastatic cutaneous nodal squamous cell carcinoma of the head and neck: Poor outcome unrelated to the index lesion.
    Head Neck. 2018 Jan 23. doi: 10.1002/hed.25069.
    PubMed     Text format     Abstract available


  59. BAUMEISTER P, Baumuller K, Harreus U, Reiter M, et al
    Evaluation of margins in head and neck squamous cell carcinoma from the surgeon's perspective.
    Head Neck. 2018 Jan 22. doi: 10.1002/hed.25061.
    PubMed     Text format     Abstract available


  60. MASCARELLA MA, Mannard E, Daniela Silva Wurzba S, Zeitouni A, et al
    Neutrophil-to-lymphocyte ratio in head and neck cancer prognosis: A systematic review and meta-analysis.
    Head Neck. 2018 Jan 22. doi: 10.1002/hed.25075.
    PubMed     Text format     Abstract available


  61. ESKANDER A, Strigenz D, Seim N, Ozer E, et al
    Submental artery island flap with simultaneous level I neck dissection.
    Head Neck. 2018 Jan 13. doi: 10.1002/hed.25044.
    PubMed     Text format     Abstract available


  62. REN Y, Deschler DG, Sajed D, Durand ML, et al
    Case of late-onset, relapsing surgical site infection related to a venous coupler placed during free flap reconstruction for major head and neck cancer.
    Head Neck. 2018 Jan 12. doi: 10.1002/hed.25043.
    PubMed     Text format     Abstract available


  63. OKER N, Verillaud B, Wassef M, Froelich S, et al
    Ethmoidal adenocarcinoma treated by exclusive endoscopic approach: Focus on learning curve and modification of management.
    Head Neck. 2018;40:126-136.
    PubMed     Text format     Abstract available


  64. LEE DJ, Chin CJ, Hong CJ, Perera S, et al
    Outpatient versus inpatient thyroidectomy: A systematic review and meta-analysis.
    Head Neck. 2018;40:192-202.
    PubMed     Text format     Abstract available


  65. KNIGGE MA, Thibeault SL
    Swallowing outcomes after cricopharyngeal myotomy: A systematic review.
    Head Neck. 2018;40:203-212.
    PubMed     Text format     Abstract available


  66. MATTAVELLI D, Schreiber A, Villaret AB, Accorona R, et al
    Complications and donor site morbidity of 3-layer reconstruction with iliotibial tract of the anterior skull base: Retrospective analysis of 186 patients.
    Head Neck. 2018;40:63-69.
    PubMed     Text format     Abstract available


  67. LANSU J, Klop WM, Heemsbergen W, Navran A, et al
    Local control in sinonasal malignant melanoma: Comparing conventional to hypofractionated radiotherapy.
    Head Neck. 2018;40:86-93.
    PubMed     Text format     Abstract available


    December 2017
  68. AVINCSAL MO, Shinomiya H, Teshima M, Kubo M, et al
    Impact of alcohol dehydrogenase-aldehyde dehydrogenase polymorphism on clinical outcome in patients with hypopharyngeal cancer.
    Head Neck. 2017 Dec 29. doi: 10.1002/hed.25050.
    PubMed     Text format     Abstract available


  69. DEJACO D, Steinbichler T, Schartinger VH, Fischer N, et al
    Prognostic value of tumor volume in patients with head and neck squamous cell carcinoma treated with primary surgery.
    Head Neck. 2017 Dec 22. doi: 10.1002/hed.25040.
    PubMed     Text format     Abstract available


  70. SON HJ, Roh JL, Choi SH, Nam SY, et al
    Nutritional and hematologic markers as predictors of risk of surgical site infection in patients with head and neck cancer undergoing major oncologic surgery.
    Head Neck. 2017 Dec 5. doi: 10.1002/hed.25031.
    PubMed     Text format     Abstract available


  71. SANABRIA A, Kowalski LP, Shah JP, Nixon IJ, et al
    Growing incidence of thyroid carcinoma in recent years: Factors underlying overdiagnosis.
    Head Neck. 2017 Dec 5. doi: 10.1002/hed.25029.
    PubMed     Text format     Abstract available


    November 2017
  72. FULCHER CD, Haigentz M Jr, Ow TJ
    AHNS Series: Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma.
    Head Neck. 2017 Nov 24. doi: 10.1002/hed.25025.
    PubMed     Text format     Abstract available


  73. ESKANDER A, Ghanem T, Agrawal A
    AHNS Series: Do you know your guidelines? Guideline recommendations for head and neck cancer of unknown primary site.
    Head Neck. 2017 Nov 21. doi: 10.1002/hed.25026.
    PubMed     Text format     Abstract available


  74. CAO C, Hu Q, Chen X
    Intensity-modulated radiotherapy for elderly patients with nasopharyngeal carcinoma.
    Head Neck. 2017 Nov 20. doi: 10.1002/hed.25016.
    PubMed     Text format     Abstract available


  75. WONG DJY, Donaldson C, Lai LT, Coleman A, et al
    Safety and effectiveness of endovascular embolization or stent-graft reconstruction for treatment of acute carotid blowout syndrome in patients with head and neck cancer: Case series and systematic review of observational studies.
    Head Neck. 2017 Nov 20. doi: 10.1002/hed.25018.
    PubMed     Text format     Abstract available


  76. LECHELT LA, Rieger JM, Cowan K, Debenham BJ, et al
    Top 10 research priorities in head and neck cancer: Results of an Alberta priority setting partnership of patients, caregivers, family members, and clinicians.
    Head Neck. 2017 Nov 17. doi: 10.1002/hed.24998.
    PubMed     Text format     Abstract available


  77. MAYS AC, Bartels HG, Wistermayer PR, Rohlfing ML, et al
    Potential for health care cost savings with preoperative gastrostomy tube placement in the head and neck cancer population.
    Head Neck. 2017 Nov 13. doi: 10.1002/hed.24992.
    PubMed     Text format     Abstract available


  78. LEONG YH, Soon YY, Lee KM, Wong LC, et al
    Long-term outcomes after reirradiation in nasopharyngeal carcinoma with intensity-modulated radiotherapy: A meta-analysis.
    Head Neck. 2017 Nov 11. doi: 10.1002/hed.24993.
    PubMed     Text format     Abstract available


  79. DAVIDI ES, Dreifuss T, Motiei M, Shai E, et al
    Cisplatin-conjugated gold nanoparticles as a theranostic agent for head and neck cancer.
    Head Neck. 2017 Nov 11. doi: 10.1002/hed.24935.
    PubMed     Text format     Abstract available


  80. KAMSTRA JI, van Leeuwen M, Roodenburg JLN, Dijkstra PU, et al
    Exercise therapy for trismus secondary to head and neck cancer: A systematic review.
    Head Neck. 2017;39:2352-2362.
    PubMed     Text format     Abstract available


    October 2017
  81. CHAN JYW, Wong STS, Wei WI
    Stage II recurrent nasopharyngeal carcinoma: Prognostic significance of retropharyngeal nodal metastasis, parapharyngeal invasion, and carotid encasement.
    Head Neck. 2017 Oct 30. doi: 10.1002/hed.24976.
    PubMed     Text format     Abstract available


  82. TAMAKI A, Miles BA, Lango M, Kowalski L, et al
    AHNS Series: Do you know your guidelines? Review of current knowledge on laryngeal cancer.
    Head Neck. 2017 Oct 27. doi: 10.1002/hed.24862.
    PubMed     Text format     Abstract available


  83. TAKENAKA Y, Oya R, Kitamiura T, Ashida N, et al
    Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: A meta-analysis.
    Head Neck. 2017 Oct 27. doi: 10.1002/hed.24986.
    PubMed     Text format     Abstract available


  84. PENG S, Wu C, Sun W, Liu D, et al
    Snail-mediated cancer stem cell-like phenotype in human CNE2 nasopharyngeal carcinoma cell.
    Head Neck. 2017 Oct 12. doi: 10.1002/hed.24982.
    PubMed     Text format     Abstract available


  85. HUANG WB, Wong STS, Chan JYW
    Role of surgery in the treatment of osteoradionecrosis and its complications after radiotherapy for nasopharyngeal carcinoma.
    Head Neck. 2017 Oct 9. doi: 10.1002/hed.24973.
    PubMed     Text format     Abstract available


  86. LIU JC
    Head and Neck Cancer, Multimodality Management, 2nd ed, Editor: Jacques Bernier Jeffrey C. Liu Springer, Switzerland, 2016, USD $329, 878 pages.
    Head Neck. 2017 Oct 5. doi: 10.1002/hed.24920.
    PubMed     Text format    


    September 2017
  87. FAN CY, Chao HL, Lin CS, Huang WY, et al
    Risk of depressive disorder among patients with head and neck cancer: A nationwide population-based study.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24961.
    PubMed     Text format     Abstract available


  88. LECHIEN JR, Nassri A, Kindt N, Brown DN, et al
    Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24939.
    PubMed     Text format     Abstract available


  89. ONG HS, Gokavarapu S, Al-Qamachi L, Yin MY, et al
    Justification of routine venous thromboembolism prophylaxis in head and neck cancer reconstructive surgery.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24914.
    PubMed     Text format     Abstract available


  90. BURNS CL, Kularatna S, Ward EC, Hill AJ, et al
    Cost analysis of a speech pathology synchronous telepractice service for patients with head and neck cancer.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24916.
    PubMed     Text format     Abstract available


  91. LOMBARDI D, Paderno A, Giordano D, Barbieri D, et al
    Therapeutic lateral neck dissection in well-differentiated thyroid cancer: Analysis on factors predicting distribution of positive nodes and prognosis.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24936.
    PubMed     Text format     Abstract available


  92. AVILES-JURADO FX, Flores JC, Guma J, Ceperuelo-Mallafre V, et al
    Prognostic relevance of insulin resistance on disease-free survival in head and neck squamous cell carcinomas: Preliminary results.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24919.
    PubMed     Text format     Abstract available


  93. QIU J, Lv B, Fu M, Wang X, et al
    18 F-Fluoromisonidazole positron emission tomography/CT-guided volumetric-modulated arc therapy-based dose escalation for hypoxic subvolume in nasopharyngeal carcinomas: A feasibility study.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24925.
    PubMed     Text format     Abstract available


  94. LIU H, Zhang Y, Zhang T, Li F, et al
    Correlation between the pathology and clinical presentations in patients with adenoid cystic carcinoma of the external auditory canal.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24915.
    PubMed     Text format     Abstract available


  95. KAWAKITA D, Lee YA, Li Q, Chen Y, et al
    Impact of oral hygiene on head and neck cancer risk in a Chinese population.
    Head Neck. 2017 Sep 27. doi: 10.1002/hed.24929.
    PubMed     Text format     Abstract available


  96. LUCIONI M, D'Ascanio L, De Nardi E, Lionello M, et al
    Management of paratracheal lymph nodes in laryngeal cancer with subglottic involvement.
    Head Neck. 2017 Sep 27. doi: 10.1002/hed.24905.
    PubMed     Text format     Abstract available


  97. CHENG SJ, Chang CF, Ko HH, Lee JJ, et al
    Hypermethylated ZNF582 and PAX1 genes in mouth rinse samples as biomarkers for oral dysplasia and oral cancer detection.
    Head Neck. 2017 Sep 27. doi: 10.1002/hed.24958.
    PubMed     Text format     Abstract available


  98. ITO M, Kodaira T, Tachibana H, Tomita N, et al
    Clinical results of definitive chemoradiotherapy for cervical esophageal cancer: Comparison of failure pattern and toxicities between intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy.
    Head Neck. 2017 Sep 27. doi: 10.1002/hed.24909.
    PubMed     Text format     Abstract available


  99. ZHANG H, Kim S, Chen Z, Nannapaneni S, et al
    Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma.
    Head Neck. 2017 Sep 25. doi: 10.1002/hed.24911.
    PubMed     Text format     Abstract available


  100. DA FONSECA FL, Yamanaka PK, Mazoti L, Arakawa-Sugueno L, et al
    Correlation among ocular surface disease, xerostomia, and nasal symptoms in patients with differentiated thyroid carcinoma subjected to radioiodine therapy: A prospective comparative study.
    Head Neck. 2017 Sep 25. doi: 10.1002/hed.24895.
    PubMed     Text format     Abstract available


    August 2017
  101. BERWOUTS D, Madani I, Duprez F, Olteanu AL, et al
    Long-term outcome of 18 F-fluorodeoxyglucose-positron emission tomography-guided dose painting for head and neck cancer: Matched case-control study.
    Head Neck. 2017 Aug 21. doi: 10.1002/hed.24892.
    PubMed     Text format     Abstract available


  102. DE BREE R, Wolf GT, de Keizer B, Nixon IJ, et al
    Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond.
    Head Neck. 2017 Aug 17. doi: 10.1002/hed.24883.
    PubMed     Text format     Abstract available


  103. KAWADA T, Takahashi H, Sakakura K, Ida S, et al
    Circulating tumor cells in patients with head and neck squamous cell carcinoma: Feasibility of detection and quantitation.
    Head Neck. 2017 Aug 17. doi: 10.1002/hed.24893.
    PubMed     Text format     Abstract available


  104. FANELLI MF, Oliveira TB, Braun AC, Corassa M, et al
    Evaluation of incidence, significance, and prognostic role of circulating tumor microemboli and transforming growth factor-beta receptor I in head and neck cancer.
    Head Neck. 2017 Aug 17. doi: 10.1002/hed.24899.
    PubMed     Text format     Abstract available


  105. LACCOURREYE O, Bonfils P, Malinvaud D, Menard M, et al
    Survival and laryngeal preservation tradeoff in advanced laryngeal cancer: From the otorhinolaryngology patient to the managing physician.
    Head Neck. 2017 Aug 8. doi: 10.1002/hed.24833.
    PubMed     Text format     Abstract available


  106. KRAAIJENGA SAC, Molen LV, Stuiver MM, Takes RP, et al
    Efficacy of a novel swallowing exercise program for chronic dysphagia in long-term head and neck cancer survivors.
    Head Neck. 2017 Aug 2. doi: 10.1002/hed.24710.
    PubMed     Text format     Abstract available


  107. ASTRUP GL, Rustoen T, Hofso K, Gran JM, et al
    Symptom burden and patient characteristics: Association with quality of life in patients with head and neck cancer undergoing radiotherapy.
    Head Neck. 2017 Aug 2. doi: 10.1002/hed.24875.
    PubMed     Text format     Abstract available


    July 2017
  108. GREEN R, Macmillan MT, Tikka T, Bruce L, et al
    Analysis of the incidence and factors predictive of outcome in patients with head and neck cancer with pulmonary nodules.
    Head Neck. 2017 Jul 25. doi: 10.1002/hed.24885.
    PubMed     Text format     Abstract available


  109. KO HC, Chen S, Wieland AM, Yu M, et al
    Clinical outcomes for patients presenting with N3 head and neck squamous cell carcinoma: Analysis of the National Cancer Database.
    Head Neck. 2017 Jul 24. doi: 10.1002/hed.24881.
    PubMed     Text format     Abstract available


  110. MALIK A, Sahu A, Singh SP, Deshmukh A, et al
    In vivo Raman spectroscopy-assisted early identification of potential second primary/recurrences in oral cancers: An exploratory study.
    Head Neck. 2017 Jul 24. doi: 10.1002/hed.24884.
    PubMed     Text format     Abstract available


  111. MARINA M, Ceda GP, Corcione L, Sgargi P, et al
    Size of thyroid carcinoma by histotype and variants: A population-based study in a mildly iodine-deficient area.
    Head Neck. 2017 Jul 24. doi: 10.1002/hed.24877.
    PubMed     Text format     Abstract available


  112. CZERWONKA L, Bissada E, Goldstein DP, Wood RE, et al
    High-resolution cone-beam computed tomography for assessment of bone invasion in oral cancer: Comparison with conventional computed tomography.
    Head Neck. 2017 Jul 12. doi: 10.1002/hed.24858.
    PubMed     Text format     Abstract available


  113. CHENG CT, Lin CY, Hung-Chun Cheng S, Lin YP, et al
    Survival benefit of surgical approach for advanced oropharyngeal and hypopharyngeal cancer: A retrospective analysis.
    Head Neck. 2017 Jul 10. doi: 10.1002/hed.24869.
    PubMed     Text format     Abstract available


  114. CHANG PH, Yeh KY, Wang CH, Chen EY, et al
    Impact of the pretreatment Glasgow prognostic score on treatment tolerance, toxicities, and survival in patients with advanced head and neck cancer undergoing concurrent chemoradiotherapy.
    Head Neck. 2017 Jul 7. doi: 10.1002/hed.24853.
    PubMed     Text format     Abstract available


  115. FLETCHER KT, Gal TJ, Ebelhar AJ, Valentino J, et al
    Prognostic indicators and survival in salvage surgery for laryngeal cancer.
    Head Neck. 2017 Jul 6. doi: 10.1002/hed.24860.
    PubMed     Text format     Abstract available


  116. SHAH-BECKER S, Pennock M, Sinoway L, Goldenberg D, et al
    Baroreceptor reflex failure: Review of the literature and the potential impact on patients with head and neck cancer.
    Head Neck. 2017 Jul 4. doi: 10.1002/hed.24857.
    PubMed     Text format     Abstract available


    June 2017
  117. DUPREZ F, Berwouts D, De Neve W, Bonte K, et al
    Distant metastases in head and neck cancer.
    Head Neck. 2017 Jun 26. doi: 10.1002/hed.24687.
    PubMed     Text format     Abstract available


  118. REID PA, Wilson P, Li Y, Marcu LG, et al
    Current understanding of cancer stem cells: Review of their radiobiology and role in head and neck cancers.
    Head Neck. 2017 Jun 23. doi: 10.1002/hed.24848.
    PubMed     Text format     Abstract available


  119. BEECHER S, Wrafter PF, Joyce CW, Regan PJ, et al
    High-risk squamous cell carcinoma of the ear - A potential role for sentinel node biopsy.
    Head Neck. 2017 Jun 22. doi: 10.1002/hed.24843.
    PubMed     Text format     Abstract available


  120. MASSA ST, Cass LM, Osazuwa-Peters N, Christopher KM, et al
    Decreased cancer-independent life expectancy in the head and neck cancer population.
    Head Neck. 2017 Jun 22. doi: 10.1002/hed.24850.
    PubMed     Text format     Abstract available


  121. VILASECA I, Valls-Mateus M, Nogues A, Lehrer E, et al
    Usefulness of office examination with narrow band imaging for the diagnosis of head and neck squamous cell carcinoma and follow-up of premalignant lesions.
    Head Neck. 2017 Jun 22. doi: 10.1002/hed.24849.
    PubMed     Text format     Abstract available


  122. TING Y, Chee J, Charn TC, Loh KS, et al
    Prognostic significance of cystic lymph nodal metastasis in nasopharyngeal carcinoma.
    Head Neck. 2017 Jun 22. doi: 10.1002/hed.24844.
    PubMed     Text format     Abstract available


  123. BARBER B, Harris J, Shillington C, Rychlik S, et al
    Efficacy of a high-observation protocol in major head and neck cancer surgery: A prospective study.
    Head Neck. 2017 Jun 20. doi: 10.1002/hed.24599.
    PubMed     Text format     Abstract available


  124. ESKANDER A, Mifsud M, Irish J, Gullane P, et al
    Overview of surgery for laryngeal and hypopharyngeal cancer in Ontario, 2003-2010.
    Head Neck. 2017 Jun 7. doi: 10.1002/hed.24787.
    PubMed     Text format     Abstract available


  125. TAMJID B, Phan P, John T, Mitchell P, et al
    Outcomes for patients with synchronous and metachronous primary lung cancer after diagnosis of head and neck cancer.
    Head Neck. 2017 Jun 7. doi: 10.1002/hed.24751.
    PubMed     Text format     Abstract available


  126. MOHANTI BK, Thakar A, Kaur J, Bahadur S, et al
    Postoperative radiotherapy dose requirement in standard combined-modality practice for head and neck squamous cell carcinoma: Analysis of salient surgical and radiotherapy parameters in 2 cohorts.
    Head Neck. 2017 Jun 6. doi: 10.1002/hed.24836.
    PubMed     Text format     Abstract available


  127. SAITO Y, Omura G, Yasuhara K, Rikitake R, et al
    Prognostic value of lymphovascular invasion of the primary tumor in hypopharyngeal carcinoma after total laryngopharyngectomy.
    Head Neck. 2017 Jun 5. doi: 10.1002/hed.24705.
    PubMed     Text format     Abstract available


  128. D'SOUZA W, Pradhan S, Saranath D
    Multiple single nucleotide polymorphism analysis and association of specific genotypes in FHIT, SAMD4A, and ANKRD17 in Indian patients with oral cancer.
    Head Neck. 2017 Jun 5. doi: 10.1002/hed.24798.
    PubMed     Text format     Abstract available


    May 2017
  129. MEZI S, Chiappetta C, Carletti R, Nardini A, et al
    Clinical significance of epithelial-to-mesenchymal transition in laryngeal carcinoma: its role in the different subsites.
    Head Neck. 2017 May 31. doi: 10.1002/hed.24838.
    PubMed     Text format     Abstract available


  130. MARUCCI L, Farneti A, Di Ridolfi P, Pinnaro P, et al
    Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer.
    Head Neck. 2017 May 31. doi: 10.1002/hed.24832.
    PubMed     Text format     Abstract available


  131. MIFSUD M, Eskander A, Irish J, Gullane P, et al
    Evolving trends in head and neck cancer epidemiology: Ontario, Canada 1993-2010.
    Head Neck. 2017 May 30. doi: 10.1002/hed.24829.
    PubMed     Text format     Abstract available


  132. HONDA K, Asato R, Tsuji J, Miyazaki M, et al
    Oncologic safety of cervical nerve preservation in neck dissection for head and neck cancer.
    Head Neck. 2017 May 30. doi: 10.1002/hed.24826.
    PubMed     Text format     Abstract available


  133. ZAIRIS S, Margalit DN, Royce TJ, Powlis WD, et al
    Prospective analysis of radiation oncology image and plan-driven peer review for head and neck cancer.
    Head Neck. 2017 May 17. doi: 10.1002/hed.24800.
    PubMed     Text format     Abstract available


  134. LEE JH, Hwang Y, Song RY, Yi JW, et al
    Relationship between iodine levels and papillary thyroid carcinoma: A systematic review and meta-analysis.
    Head Neck. 2017 May 17. doi: 10.1002/hed.24797.
    PubMed     Text format     Abstract available


  135. SEKINE T, Barbosa FG, Delso G, Burger IA, et al
    Local resectability assessment of head and neck cancer: Positron emission tomography/MRI versus positron emission tomography/CT.
    Head Neck. 2017 May 13. doi: 10.1002/hed.24783.
    PubMed     Text format     Abstract available


  136. ERKAN S, Savundra JM, Wood B, Acharya AN, et al
    Clinical perineural invasion of the trigeminal and facial nerves in cutaneous head and neck squamous cell carcinoma: Outcomes and prognostic implications of multimodality and salvage treatment.
    Head Neck. 2017 May 5. doi: 10.1002/hed.24607.
    PubMed     Text format     Abstract available


  137. WEISS BG, Ihler F, Wolff HA, Schneider S, et al
    Transoral laser microsurgery for treatment for hypopharyngeal cancer in 211 patients.
    Head Neck. 2017 May 5. doi: 10.1002/hed.24814.
    PubMed     Text format     Abstract available


  138. HINSON AM, Massoll NA, Jolly LA, Stack BC Jr, et al
    Structural alterations in tumor-draining lymph nodes before papillary thyroid carcinoma metastasis.
    Head Neck. 2017 May 3. doi: 10.1002/hed.24807.
    PubMed     Text format     Abstract available


  139. ZHANG D, Li F, Wu CW, Liu X, et al
    Percutaneous probe stimulation for intraoperative neuromonitoring in total endoscopic thyroidectomy: A preliminary experience.
    Head Neck. 2017;39:1001-1007.
    PubMed     Text format     Abstract available


  140. LOPEZ F, Triantafyllou A, Snyderman CH, Hunt JL, et al
    Nasal juvenile angiofibroma: Current perspectives with emphasis on management.
    Head Neck. 2017;39:1033-1045.
    PubMed     Text format     Abstract available


  141. WELLER MA, Ward MC, Berriochoa C, Reddy CA, et al
    Predictors of distant metastasis in human papillomavirus-associated oropharyngeal cancer.
    Head Neck. 2017;39:940-946.
    PubMed     Text format     Abstract available


  142. MORISOD B, Venara-Vulpe II, Alzuphar S, Monnier Y, et al
    Minimizing adjuvant treatment after transoral robotic surgery through surgical margin revision and exclusion of radiographic extracapsular extension: A Prospective observational cohort study.
    Head Neck. 2017;39:965-973.
    PubMed     Text format     Abstract available


  143. LANSAAT L, van den Boer C, Muller SH, van der Noort V, et al
    Ex vivo humidifying capacity and patient acceptability of stoma cloths in laryngectomized individuals.
    Head Neck. 2017;39:921-931.
    PubMed     Text format     Abstract available


    April 2017
  144. AGRAWAL N, Evasovich MR, Kandil E, Noureldine SI, et al
    Indications and extent of central neck dissection for papillary thyroid cancer: An American Head and Neck Society Consensus Statement.
    Head Neck. 2017 Apr 27. doi: 10.1002/hed.24715.
    PubMed     Text format     Abstract available


  145. CHANG PH, Yeh KY, Wang CH, Chen EY, et al
    Impact of metformin on patients with advanced head and neck cancer undergoing concurrent chemoradiotherapy.
    Head Neck. 2017 Apr 27. doi: 10.1002/hed.24793.
    PubMed     Text format     Abstract available


  146. LIU SY, Feng IJ, Wu YW, Chen CY, et al
    Implication for second primary cancer from visible oral and oropharyngeal premalignant lesions in betel-nut chewing related oral cancer.
    Head Neck. 2017 Apr 6. doi: 10.1002/hed.24777.
    PubMed     Text format     Abstract available


  147. GARCIA-OLMO DC, Contreras JD, Picazo MG, Lopez-Torres J, et al
    Potential clinical significance of perioperative levels of mRNA in plasma from patients with cancer of the larynx or hypopharynx.
    Head Neck. 2017;39:647-655.
    PubMed     Text format     Abstract available


  148. VAN LOON Y, Stiggelbout AM, Hakkesteegt MM, Langeveld TP, et al
    Utility approach to decision-making in extended T1 and limited T2 glottic carcinoma.
    Head Neck. 2017;39:779-785.
    PubMed     Text format     Abstract available


  149. DUEK I, Amit M, Sviri GE, Gil Z, et al
    Combined endoscopic transcervical-transoral robotic approach for resection of parapharyngeal space tumors.
    Head Neck. 2017;39:786-790.
    PubMed     Text format     Abstract available


  150. ZHOU L, Luo W
    Vascular endothelial growth factor-targeted paclitaxel-loaded liposome microbubbles and inhibition of human epidermoid-2 cell proliferation.
    Head Neck. 2017;39:656-661.
    PubMed     Text format     Abstract available


  151. TURRI-ZANONI M, Salzano G, Lambertoni A, Giovannardi M, et al
    Prognostic value of pretreatment peripheral blood markers in paranasal sinus cancer: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio.
    Head Neck. 2017;39:730-736.
    PubMed     Text format     Abstract available


  152. ALMADORI G, Lauriola L, Coli A, Bussu F, et al
    Minichromosome maintenance protein 7 and geminin expression: Prognostic value in laryngeal squamous cell carcinoma in patients treated with radiotherapy and cetuximab.
    Head Neck. 2017;39:684-693.
    PubMed     Text format     Abstract available


  153. TURRI-ZANONI M, Battaglia P, Karligkiotis A, Lepera D, et al
    Transnasal endoscopic partial maxillectomy: Operative nuances and proposal for a comprehensive classification system based on 1378 cases.
    Head Neck. 2017;39:754-766.
    PubMed     Text format     Abstract available


    March 2017
  154. TIGHE DF, Thomas AJ, Sassoon I, Kinsman R, et al
    Developing a risk stratification tool for audit of outcome after surgery for head and neck squamous cell carcinoma.
    Head Neck. 2017 Mar 29. doi: 10.1002/hed.24769.
    PubMed     Text format     Abstract available


  155. RIDDER M, Klop M, Hamming-Vrieze O, Boer J, et al
    Unknown primary head and neck squamous cell carcinoma in the era of fluorodeoxyglucose-positron emission tomography/CT and intensity-modulated radiotherapy.
    Head Neck. 2017 Mar 28. doi: 10.1002/hed.24762.
    PubMed     Text format     Abstract available


  156. REYES-GIBBY CC, Melkonian SC, Hanna EY, Yeung SJ, et al
    Cohort study of oncologic emergencies in patients with head and neck cancer.
    Head Neck. 2017 Mar 27. doi: 10.1002/hed.24748.
    PubMed     Text format     Abstract available


  157. WANG YY, Chen YK, Hsu YL, Chiu WC, et al
    Synthetic beta-nitrostyrene derivative CYT-Rx20 as inhibitor of oral cancer cell proliferation and tumor growth through glutathione suppression and reactive oxygen species induction.
    Head Neck. 2017 Mar 27. doi: 10.1002/hed.24664.
    PubMed     Text format     Abstract available


  158. GAMA RR, Song Y, Zhang Q, Brown MC, et al
    Body mass index and prognosis in patients with head and neck cancer.
    Head Neck. 2017 Mar 21. doi: 10.1002/hed.24760.
    PubMed     Text format     Abstract available


  159. STOKES WA, Amini A, Jones BL, McDermott JD, et al
    Survival impact of induction chemotherapy in advanced head and neck cancer: A National Cancer Database analysis.
    Head Neck. 2017 Mar 16. doi: 10.1002/hed.24739.
    PubMed     Text format     Abstract available


  160. GUO T, Goldenberg D, Fakhry C
    AHNS series: Do you know your guidelines? Management of head and neck cancer in the era of human papillomavirus: Educating our patients on human papillomavirus.
    Head Neck. 2017 Mar 6. doi: 10.1002/hed.24693.
    PubMed     Text format     Abstract available


  161. BOTS WT, van den Bosch S, Zwijnenburg EM, Dijkema T, et al
    Reirradiation of head and neck cancer: Long-term disease control and toxicity.
    Head Neck. 2017 Mar 6. doi: 10.1002/hed.24733.
    PubMed     Text format     Abstract available


  162. CHAPUT A, Calais J, Robin P, Thureau S, et al
    Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
    Head Neck. 2017 Mar 6. doi: 10.1002/hed.24738.
    PubMed     Text format     Abstract available


  163. AMOILS M, Lee CS, Sunwoo J, Aasi SZ, et al
    Node-positive cutaneous squamous cell carcinoma of the head and neck: Survival, high-risk features, and adjuvant chemoradiotherapy outcomes.
    Head Neck. 2017 Mar 2. doi: 10.1002/hed.24692.
    PubMed     Text format     Abstract available


  164. PATIL VM, Noronha V, Joshi A, Ramaswamy A, et al
    Neoadjuvant chemotherapy in geriatric head and neck cancers.
    Head Neck. 2017 Mar 1. doi: 10.1002/hed.24694.
    PubMed     Text format     Abstract available


  165. SIDDIQUI F, Smith RV, Yom SS, Beitler JJ, et al
    ACR appropriateness criteria((R)) nasal cavity and paranasal sinus cancers.
    Head Neck. 2017;39:407-418.
    PubMed     Text format     Abstract available


  166. IWAKI S, Maeda T, Saito M, Otsuki N, et al
    Role of immediate recurrent laryngeal nerve reconstruction in surgery for thyroid cancers with fixed vocal cords.
    Head Neck. 2017;39:427-431.
    PubMed     Text format     Abstract available


  167. NISHIO N, Fujii M, Hayashi Y, Hiramatsu M, et al
    Preoperative surgical simulation and validation of the line of resection in anterolateral craniofacial resection of advanced sinonasal sinus carcinoma.
    Head Neck. 2017;39:512-519.
    PubMed     Text format     Abstract available


  168. LOMBARDI D, Mattavelli D, Redaelli De Zinis LO, Accorona R, et al
    Primary Ewing's sarcoma of the sinonasal tract in adults: A challenging disease.
    Head Neck. 2017;39:E45-E50.
    PubMed     Text format     Abstract available


  169. SIVARS L, Landin D, Haeggblom L, Tertipis N, et al
    Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study.
    Head Neck. 2017;39:419-426.
    PubMed     Text format     Abstract available


  170. MATTHEIS S, Hasskamp P, Holtmann L, Schafer C, et al
    Flex Robotic System in transoral robotic surgery: The first 40 patients.
    Head Neck. 2017;39:471-475.
    PubMed     Text format     Abstract available


  171. YU Y, Mabray M, Silveira W, Shen PY, et al
    Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
    Head Neck. 2017;39:432-438.
    PubMed     Text format     Abstract available


    February 2017
  172. WALLINE HM, Goudsmit CM, McHugh JB, Tang AL, et al
    Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell lines.
    Head Neck. 2017 Feb 25. doi: 10.1002/hed.24729.
    PubMed     Text format     Abstract available


  173. ROSKO A, Birkeland A, Shuman A, Prince M, et al
    Positron emission tomography-CT prediction of occult nodal metastasis in recurrent laryngeal cancer.
    Head Neck. 2017 Feb 25. doi: 10.1002/hed.24719.
    PubMed     Text format     Abstract available


  174. BROWN TE, Wittholz K, Way M, Banks MD, et al
    Investigation of p16 status, chemotherapy regimen, and other nutrition markers for predicting gastrostomy in patients with head and neck cancer.
    Head Neck. 2017 Feb 23. doi: 10.1002/hed.24630.
    PubMed     Text format     Abstract available



  175. International Head and Neck Cancer Epidemiology Consortium: Update No. 23.
    Head Neck. 2017 Feb 23. doi: 10.1002/hed.24651.
    PubMed     Text format    


  176. BURNS CL, Ward EC, Hill AJ, Kularatna S, et al
    Randomized controlled trial of a multisite speech pathology telepractice service providing swallowing and communication intervention to patients with head and neck cancer: Evaluation of service outcomes.
    Head Neck. 2017 Feb 22. doi: 10.1002/hed.24706.
    PubMed     Text format     Abstract available


  177. AFFOLTER A, Samosny G, Heimes AS, Schneider J, et al
    Multikinase inhibitors sorafenib and sunitinib as radiosensitizers in head and neck cancer cell lines.
    Head Neck. 2017 Feb 21. doi: 10.1002/hed.24557.
    PubMed     Text format     Abstract available


  178. HIRSHOREN N, Danne J, Dixon BJ, Magarey M, et al
    Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
    Head Neck. 2017 Feb 15. doi: 10.1002/hed.24683.
    PubMed     Text format     Abstract available


  179. AGARWAL J, Krishnatry R, Chaturvedi P, Ghosh-Laskar S, et al
    Survey of return to work of head and neck cancer survivors: A report from a tertiary cancer center in India.
    Head Neck. 2017 Feb 7. doi: 10.1002/hed.24703.
    PubMed     Text format     Abstract available


  180. ENZENHOFER E, Kadletz L, Stanisz I, Kotowski U, et al
    Effect of the histone deacetylase inhibitor resminostat on head and neck squamous cell carcinoma cell lines.
    Head Neck. 2017 Feb 7. doi: 10.1002/hed.24699.
    PubMed     Text format     Abstract available


  181. TSELIS N, Karagiannis E, Kolotas C, Baghi M, et al
    Image-guided interstitial high-dose-rate brachytherapy in the treatment of inoperable recurrent head and neck malignancies: An effective option of reirradiation.
    Head Neck. 2017 Feb 7. doi: 10.1002/hed.24697.
    PubMed     Text format     Abstract available


  182. AXELSSON L, Silander E, Nyman J, Bove M, et al
    Effect of prophylactic percutaneous endoscopic gastrostomy tube on swallowing in advanced head and neck cancer: A randomized controlled study.
    Head Neck. 2017 Feb 2. doi: 10.1002/hed.24707.
    PubMed     Text format     Abstract available


  183. GOOI Z, Richmon J, Agrawal N, Blair E, et al
    AHNS Series - Do you know your guidelines? Principles of treatment for nasopharyngeal cancer: A review of the National Comprehensive Cancer Network guidelines.
    Head Neck. 2017;39:201-205.
    PubMed     Text format     Abstract available


  184. FRISCH T
    Versatility of the facial artery myomucosal island flap in neopharyngeal reconstruction.
    Head Neck. 2017;39:E29-E33.
    PubMed     Text format     Abstract available


  185. MCDOWELL LJ, Jacobson MC, Levin W
    High-dose intravenous steroid regimen for radiation-induced hypoglossal nerve palsy.
    Head Neck. 2017;39:E23-E28.
    PubMed     Text format     Abstract available


  186. MEHTA V, Flores JM, Thompson RW, Nathan CA, et al
    Primary payer status, individual patient characteristics, and hospital-level factors affecting length of stay and total cost of hospitalization in total laryngectomy.
    Head Neck. 2017;39:311-319.
    PubMed     Text format     Abstract available


  187. GAVRIEL H, Eviatar E, Abu Eta R
    Hyperbaric oxygen therapy for maxillary bone radiation-induced injury: A 15-year single-center experience.
    Head Neck. 2017;39:275-278.
    PubMed     Text format     Abstract available


  188. WEAVER AN, Cooper TS, Wei S, Carroll WR, et al
    DNA-PkCS expression in oropharyngeal squamous cell carcinoma: Correlations with human papillomavirus status and recurrence after transoral robotic surgery.
    Head Neck. 2017;39:206-214.
    PubMed     Text format     Abstract available


    January 2017
  189. ROSCULET N, Zhou XC, Ha P, Tang M, et al
    Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
    Head Neck. 2017 Jan 11. doi: 10.1002/hed.24658.
    PubMed     Text format     Abstract available


  190. HOFSTEDE TM, Jacob RF, Montgomery P, Wesley P, et al
    Surgical preparation of nasal defects to enhance the implant-retained facial prostheses: A case report.
    Head Neck. 2017;39:E4-E11.
    PubMed     Text format     Abstract available


  191. ALLENSWORTH JJ, O'Dell KD, Schindler JS
    Bilateral vocal fold paralysis and dysphagia secondary to diffuse idiopathic skeletal hyperostosis.
    Head Neck. 2017;39:E1-E3.
    PubMed     Text format     Abstract available


  192. BEECH NM, Porceddu S, Batstone MD
    Radiotherapy-associated dental extractions and osteoradionecrosis.
    Head Neck. 2017;39:128-132.
    PubMed     Text format     Abstract available


  193. ANSARIN M, Cattaneo A, De Benedetto L, Zorzi S, et al
    Retrospective analysis of factors influencing oncologic outcome in 590 patients with early-intermediate glottic cancer treated by transoral laser microsurgery.
    Head Neck. 2017;39:71-81.
    PubMed     Text format     Abstract available


  194. RACKLEY TP, Namelo WC, Palaniappan N, Cole N, et al
    Unilateral radiotherapy for surgically resected lateralized squamous cell carcinoma of the tonsil.
    Head Neck. 2017;39:17-23.
    PubMed     Text format     Abstract available


  195. BAUMEISTER P, Rauch J, Jacobi C, Kisser U, et al
    Impact of comorbidity and anemia in patients with oropharyngeal cancer primarily treated with surgery in the human papillomavirus era.
    Head Neck. 2017;39:7-16.
    PubMed     Text format     Abstract available


    December 2016
  196. WANG L, Wang X, Li Y, Han S, et al
    Human papillomavirus status and the relative biological effectiveness of proton radiotherapy in head and neck cancer cells.
    Head Neck. 2016 Dec 30. doi: 10.1002/hed.24673.
    PubMed     Text format     Abstract available


  197. REPANOS C, Mirza AH, George M, Karkos PD, et al
    Timing of neck dissection in association with transoral surgery: A systematic review.
    Head Neck. 2016 Dec 29. doi: 10.1002/hed.24680.
    PubMed     Text format     Abstract available


  198. OKOYE CC, Bucher J, Tatsuoka C, Parikh SA, et al
    Cardiovascular risk and prevention in patients with head and neck cancer treated with radiotherapy.
    Head Neck. 2016 Dec 29. doi: 10.1002/hed.24646.
    PubMed     Text format     Abstract available


  199. KWON M, Kim RB, Roh JL, Lee SW, et al
    Prevalence and clinical significance of cancer cachexia based on time from treatment in advanced-stage head and neck squamous cell carcinoma.
    Head Neck. 2016 Dec 21. doi: 10.1002/hed.24672.
    PubMed     Text format     Abstract available


  200. CANNADY SB, Hatten KM, Bur AM, Brant J, et al
    Use of free tissue transfer in head and neck cancer surgery and risk of overall and serious complication(s): An American College of Surgeons-National Surgical Quality Improvement Project analysis of free tissue transfer to the head and neck.
    Head Neck. 2016 Dec 21. doi: 10.1002/hed.24669.
    PubMed     Text format     Abstract available


  201. DU XJ, Chen L, Li WF, Tang LL, et al
    Use of pretreatment serum uric acid level to predict metastasis in locally advanced nasopharyngeal carcinoma.
    Head Neck. 2016 Dec 20. doi: 10.1002/hed.24631.
    PubMed     Text format     Abstract available


  202. BALIGA S, Kabarriti R, Ohri N, Haynes-Lewis H, et al
    Stereotactic body radiotherapy for recurrent head and neck cancer: A critical review.
    Head Neck. 2016 Dec 20. doi: 10.1002/hed.24633.
    PubMed     Text format     Abstract available


  203. MILLER MC, Goldenberg D
    AHNS Series: Do you know your guidelines? Principles of surgery for head and neck cancer: A review of the National Comprehensive Cancer Network guidelines.
    Head Neck. 2016 Dec 16. doi: 10.1002/hed.24654.
    PubMed     Text format     Abstract available


    November 2016
  204. HAAPANIEMI A, Vaisanen J, Atula T, Alho OP, et al
    Predictive factors and treatment outcome of laryngeal carcinoma recurrence.
    Head Neck. 2016 Nov 30. doi: 10.1002/hed.24642.
    PubMed     Text format     Abstract available


  205. CHAN OS, Sze HC, Lee MC, Chan LL, et al
    Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma.
    Head Neck. 2016 Nov 29. doi: 10.1002/hed.24645.
    PubMed     Text format     Abstract available



  206. International Head and Neck Cancer Epidemiology Consortium: Update No. 22.
    Head Neck. 2016 Nov 25. doi: 10.1002/hed.24510.
    PubMed     Text format    


  207. MATSUMOTO Y, Sakurai H, Kogashiwa Y, Kimura T, et al
    Inhibition of epithelial-mesenchymal transition by cetuximab via the EGFR-GEP100-Arf6-AMAP1 pathway in head and neck cancer.
    Head Neck. 2016 Nov 23. doi: 10.1002/hed.24626.
    PubMed     Text format     Abstract available


  208. ROERINK SH, Coolen L, Schenning ME, Husson O, et al
    High prevalence of self-reported shoulder complaints after thyroid carcinoma surgery.
    Head Neck. 2016 Nov 12. doi: 10.1002/hed.24579.
    PubMed     Text format     Abstract available


  209. BECK TN, Smith CH, Flieder DB, Galloway TJ, et al
    Head and neck squamous cell carcinoma: Ambiguous human papillomavirus status, elevated p16, and deleted retinoblastoma 1.
    Head Neck. 2016 Nov 8. doi: 10.1002/hed.24604.
    PubMed     Text format     Abstract available


    October 2016
  210. FARRELL E, Heffron C, Murphy M, O'Leary G, et al
    Impact of lymphocytic thyroiditis on incidence of pathological incidental thyroid carcinoma.
    Head Neck. 2016 Oct 28. doi: 10.1002/hed.24544.
    PubMed     Text format     Abstract available


  211. VAN LIEW JR, Brock RL, Christensen AJ, Karnell LH, et al
    Weight loss after head and neck cancer: A dynamic relationship with depressive symptoms.
    Head Neck. 2016 Oct 5. doi: 10.1002/hed.24601.
    PubMed     Text format     Abstract available


  212. LEE JH, Shin HJ, Yoon JH, Kim EK, et al
    Predicting lymph node metastasis in patients with papillary thyroid carcinoma by vascular index on power Doppler ultrasound.
    Head Neck. 2016 Oct 5. doi: 10.1002/hed.24592.
    PubMed     Text format     Abstract available


  213. YALNIZ Z, Demokan S, Karabulut B, Ulusan M, et al
    Copy number profiling of tumor suppressor genes in head and neck cancer.
    Head Neck. 2016 Oct 3. doi: 10.1002/hed.24593.
    PubMed     Text format     Abstract available


  214. CHEN WC, Lai CH, Chuang HC, Lin PY, et al
    Inflammation-induced myeloid-derived suppressor cells associated with squamous cell carcinoma of the head and neck.
    Head Neck. 2016 Oct 3. doi: 10.1002/hed.24595.
    PubMed     Text format     Abstract available


    September 2016
  215. CHUNG CH, Germain A, Subramaniam RM, Heilmann AM, et al
    Genomic alterations in human epidermal growth factor receptor 2 (HER2/ERBB2) in head and neck squamous cell carcinoma.
    Head Neck. 2016 Sep 21. doi: 10.1002/hed.24587.
    PubMed     Text format     Abstract available


  216. NOORLAG R, Boeve K, Witjes MJ, Koole R, et al
    Amplification and protein overexpression of cyclin D1: Predictor of occult nodal metastasis in early oral cancer.
    Head Neck. 2016 Sep 21. doi: 10.1002/hed.24584.
    PubMed     Text format     Abstract available


  217. ISHIMARU M, Ono S, Suzuki S, Matsui H, et al
    Artificial nutrition dependence after cetuximab versus cisplatin combined with radiotherapy for advanced head and neck cancer: A propensity score-matched analysis.
    Head Neck. 2016 Sep 16. doi: 10.1002/hed.24583.
    PubMed     Text format     Abstract available


  218. XU P, Min Y, Blanchard P, Feng M, et al
    Incidence of small lymph node metastases in patients with nasopharyngeal carcinoma: Clinical implications for prognosis and treatment.
    Head Neck. 2016 Sep 14. doi: 10.1002/hed.24586.
    PubMed     Text format     Abstract available


  219. LEE YB, Cho YY, Jang JY, Kim TH, et al
    Current status and diagnostic values of the Bethesda system for reporting thyroid cytopathology in a papillary thyroid carcinoma-prevalent area.
    Head Neck. 2016 Sep 12. doi: 10.1002/hed.24578.
    PubMed     Text format     Abstract available


  220. KANO S, Homma A, Hatakeyama H, Mizumachi T, et al
    Pretreatment lymphocyte-to-monocyte ratio as an independent prognostic factor for head and neck cancer.
    Head Neck. 2016 Sep 12. doi: 10.1002/hed.24576.
    PubMed     Text format     Abstract available


    August 2016
  221. POPOVTZER A, Burnstein H, Stemmer S, Limon D, et al
    Phase II organ-preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy.
    Head Neck. 2016 Aug 24. doi: 10.1002/hed.24571.
    PubMed     Text format     Abstract available


  222. VALERO C, Pardo L, Lopez M, Garcia J, et al
    Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer.
    Head Neck. 2016 Aug 18. doi: 10.1002/hed.24561.
    PubMed     Text format     Abstract available


  223. BAEK SK, Lee MC, Hah JH, Ahn SH, et al
    Role of surgery in the management of anaplastic thyroid carcinoma: Korean nationwide multicenter study of 329 patients with anaplastic thyroid carcinoma, 2000 to 2012.
    Head Neck. 2016 Aug 18. doi: 10.1002/hed.24559.
    PubMed     Text format     Abstract available


  224. BOZEC A, Ebran N, Radosevic-Robin N, Chamorey E, et al
    Combination of phosphotidylinositol-3-kinase targeting with cetuximab and irradiation: A preclinical study on an orthotopic xenograft model of head and neck cancer.
    Head Neck. 2016 Aug 10. doi: 10.1002/hed.24560.
    PubMed     Text format     Abstract available


    July 2016

  225. International head and neck cancer epidemiology consortium: Update no. 21.
    Head Neck. 2016 Jul 26. doi: 10.1002/hed.24552.
    PubMed     Text format    


  226. ROVIRA A, Tornero J, Oliva M, Taberna M, et al
    Salvage surgery after head and neck squamous cell carcinoma treated with bioradiotherapy.
    Head Neck. 2016 Jul 26. doi: 10.1002/hed.24549.
    PubMed     Text format     Abstract available


  227. WAGNER JL, Kenney RM, Vazquez JA, Ghanem TA, et al
    Surgical prophylaxis with gram-negative activity for reduction of surgical site infections after microvascular reconstruction for head and neck cancer.
    Head Neck. 2016 Jul 26. doi: 10.1002/hed.24178.
    PubMed     Text format     Abstract available


  228. LAMBERT EM, Gunn GB, Gidley PW
    Effects of radiation on the temporal bone in patients with head and neck cancer.
    Head Neck. 2016 Jul 25. doi: 10.1002/hed.24267.
    PubMed     Text format     Abstract available


  229. CHANG CF, Kuo YL, Pu C, Chou YJ, et al
    Neck dissection and stroke in patients with oral cavity cancer: A population-based cohort study.
    Head Neck. 2016 Jul 20. doi: 10.1002/hed.24535.
    PubMed     Text format     Abstract available


  230. PETERSON LA, Bellile EL, Wolf GT, Virani S, et al
    Cigarette use, comorbidities, and prognosis in a prospective head and neck squamous cell carcinoma population.
    Head Neck. 2016 Jul 19. doi: 10.1002/hed.24515.
    PubMed     Text format     Abstract available


  231. GORDON SA, Reiter ER
    Effectiveness of critical care pathways for head and neck cancer surgery: A systematic review.
    Head Neck. 2016 Jul 8. doi: 10.1002/hed.24265.
    PubMed     Text format     Abstract available


  232. CHENG OT, Tamaki A, Rezaee RP, Zender CA, et al
    Laryngotracheal reconstruction with a prefabricated fasciocutaneous free flap for recurrent papillary thyroid carcinoma.
    Head Neck. 2016 Jul 4. doi: 10.1002/hed.24530.
    PubMed     Text format     Abstract available


    June 2016
  233. HAAPIO E, Kinnunen I, Airaksinen JK, Irjala H, et al
    Excessive intravenous fluid therapy in head and neck cancer surgery.
    Head Neck. 2016 Jun 14. doi: 10.1002/hed.24525.
    PubMed     Text format     Abstract available


  234. CANADAS-GARRE M, Becerra-Massare P, Moreno Casares A, Calleja-Hernandez MA, et al
    Relevance of BRAF and NRAS mutations in the primary tumor and metastases of papillary thyroid carcinomas.
    Head Neck. 2016 Jun 14. doi: 10.1002/hed.24517.
    PubMed     Text format     Abstract available


  235. JATANA KR, Balasubramanian P, McMullen KP, Lang JC, et al
    Effect of surgical intervention on circulating tumor cells in patients with squamous cell carcinoma of the head and neck using a negative enrichment technology.
    Head Neck. 2016 Jun 5. doi: 10.1002/hed.24519.
    PubMed     Text format     Abstract available


    May 2016
  236. GEIGER JL, Bauman JE, Gibson MK, Gooding WE, et al
    Phase II trial of everolimus in patients with previously treated recurrent or metastatic head and neck squamous cell carcinoma.
    Head Neck. 2016 May 27. doi: 10.1002/hed.24501.
    PubMed     Text format     Abstract available


  237. SUGIYAMA N, Takao S, Suzuki E, Kimata Y, et al
    Risk factors of thrombosis in a single method of microsurgical head and neck reconstruction: A multi-institutional study of 773 reconstructions with a free jejunal graft after total pharyngolaryngoesophagectomy for hypopharyngeal cancer.
    Head Neck. 2016 May 26. doi: 10.1002/hed.24504.
    PubMed     Text format     Abstract available


  238. PARAHYBA CJ, Ynoe Moraes F, Ramos PA, Haddad CM, et al
    Radiation dose distribution in the teeth, maxilla, and mandible of patients with oropharyngeal and nasopharyngeal tumors who were treated with intensity-modulated radiotherapy.
    Head Neck. 2016 May 25. doi: 10.1002/hed.24479.
    PubMed     Text format     Abstract available


  239. TIAN YH, Zou WH, Xiao WW, Zeng L, et al
    Oligometastases in AJCC stage IVc nasopharyngeal carcinoma: A subset with better overall survival.
    Head Neck. 2016 May 24. doi: 10.1002/hed.24345.
    PubMed     Text format     Abstract available


  240. CABANILLAS ME, Williams MD
    Letter to the Editor regarding squamoid pattern of anaplastic thyroid carcinoma, a poorly recognized entity.
    Head Neck. 2016 May 19. doi: 10.1002/hed.24503.
    PubMed     Text format    


  241. RYAN NA, Lazic D
    Reply to Letter to the Editor regarding anaplastic thyroid carcinoma.
    Head Neck. 2016 May 19. doi: 10.1002/hed.24500.
    PubMed     Text format    


    April 2016
  242. SABA NF, Salama JK, Beitler JJ, Busse PM, et al
    ACR Appropriateness criteria(R) for nasopharyngeal carcinoma.
    Head Neck. 2016 Apr 30. doi: 10.1002/hed.24423.
    PubMed     Text format     Abstract available


  243. ROSKO AJ, Spector ME, Griffin GR, Vainshtein JM, et al
    Neurologic late effects associated with radiologic evidence of vertebral osteoradionecrosis after salvage laryngectomy: A syndrome associated with survivors of laryngeal and hypopharyngeal cancer.
    Head Neck. 2016 Apr 15. doi: 10.1002/hed.24348.
    PubMed     Text format     Abstract available


  244. OMURA G, Ando M, Saito Y, Kobayashi K, et al
    Association of the upregulated expression of focal adhesion kinase with poor prognosis and tumor dissemination in hypopharyngeal cancer.
    Head Neck. 2016 Apr 9. doi: 10.1002/hed.24176.
    PubMed     Text format     Abstract available


  245. CHOI YS, Park SG, Song EK, Cho SH, et al
    Comparison of the therapeutic effects of total laryngectomy and a larynx-preservation approach in patients with T4a laryngeal cancer and thyroid cartilage invasion: A multicenter retrospective review.
    Head Neck. 2016 Apr 4. doi: 10.1002/hed.24438.
    PubMed     Text format     Abstract available


  246. BOCHNIA M, Grabowski K, Zalewska A, Morawska-Kochman M, et al
    Angiofibrolipoma of the larynx: Case report and literature review.
    Head Neck. 2016;38:E81-3.
    PubMed     Text format     Abstract available


  247. NARWANI V, Nalamada K, Lee M, Kothari P, et al
    Readability and quality assessment of internet-based patient education materials related to laryngeal cancer.
    Head Neck. 2016;38:601-5.
    PubMed     Text format     Abstract available


  248. BUSSU F, Mura F, Micciche F, Bertino G, et al
    Oncologic outcome of hypopharyngeal carcinoma treated with different modalities at 2 different university hospitals.
    Head Neck. 2016;38:606-12.
    PubMed     Text format     Abstract available


  249. LEE HY, Cho YG, You JY, Choi BH, et al
    Traction injury of the recurrent laryngeal nerve: Results of continuous intraoperative neuromonitoring in a swine model.
    Head Neck. 2016;38:582-8.
    PubMed     Text format     Abstract available


  250. ZANDBERG DP, Liu S, Goloubeva O, Ord R, et al
    Oropharyngeal cancer as a driver of racial outcome disparities in squamous cell carcinoma of the head and neck: 10-year experience at the University of Maryland Greenebaum Cancer Center.
    Head Neck. 2016;38:564-72.
    PubMed     Text format     Abstract available


  251. WATANABE A, Taniguchi M, Kimura Y, Ito S, et al
    Efficient, effective, safe procedure to identify nonrecurrent inferior laryngeal nerve during thyroid surgery.
    Head Neck. 2016;38:573-7.
    PubMed     Text format     Abstract available


  252. DE ALMEIDA JR, Moskowitz AJ, Miles BA, Goldstein DP, et al
    Cost-effectiveness of transoral robotic surgery versus (chemo)radiotherapy for early T classification oropharyngeal carcinoma: A cost-utility analysis.
    Head Neck. 2016;38:589-600.
    PubMed     Text format     Abstract available


  253. ROBIN TP, Gan GN, Tam M, Westerly D, et al
    Safety of contralateral submandibular gland sparing in locally advanced oropharyngeal cancers: A multicenter review.
    Head Neck. 2016;38:506-11.
    PubMed     Text format     Abstract available


  254. MOHINDRA P, Urban E, Pagan JD, Geye HM, et al
    Selective omission of level V nodal coverage for patients with oropharyngeal cancer: Clinical validation of intensity-modulated radiotherapy experience and dosimetric significance.
    Head Neck. 2016;38:499-505.
    PubMed     Text format     Abstract available


  255. SCHOUTEN CS, Hakim S, Boellaard R, Bloemena E, et al
    Interaction of quantitative (18)F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.
    Head Neck. 2016;38:529-35.
    PubMed     Text format     Abstract available


  256. KOTO M, Hasegawa A, Takagi R, Sasahara G, et al
    Carbon ion radiotherapy for locally advanced squamous cell carcinoma of the external auditory canal and middle ear.
    Head Neck. 2016;38:512-6.
    PubMed     Text format     Abstract available


  257. CARRILLO JF, Carrillo LC, Cano A, Ramirez-Ortega MC, et al
    Retrospective cohort study of prognostic factors in patients with oral cavity and oropharyngeal squamous cell carcinoma.
    Head Neck. 2016;38:536-41.
    PubMed     Text format     Abstract available


  258. OHBA S, Yokoyama J, Kojima M, Fujimaki M, et al
    Significant preservation of swallowing function in chemoradiotherapy for advanced head and neck cancer by prophylactic swallowing exercise.
    Head Neck. 2016;38:517-21.
    PubMed     Text format     Abstract available


    March 2016
  259. HARRIS BN, Bhuskute AA, Rao S, Farwell DG, et al
    Primary surgery for advanced-stage laryngeal cancer: A stage and subsite-specific survival analysis.
    Head Neck. 2016 Mar 25. doi: 10.1002/hed.24443.
    PubMed     Text format     Abstract available


  260. PERETTI G, Piazza C, Penco S, Santori G, et al
    Transoral laser microsurgery as primary treatment for selected T3 glottic and supraglottic cancers.
    Head Neck. 2016 Mar 11. doi: 10.1002/hed.24424.
    PubMed     Text format     Abstract available


  261. LORINCZ BB, Mockelmann N, Busch CJ, Hezel M, et al
    Automatic periodic stimulation of the vagus nerve during single-incision transaxillary robotic thyroidectomy: Feasibility, safety, and first cases.
    Head Neck. 2016;38:482-5.
    PubMed     Text format     Abstract available


  262. CHANG MT, Schwam ZG, Hajek MA, Paskhover B, et al
    Severe epistaxis due to aberrant vasculature in a patient with STAT-1 mutation.
    Head Neck. 2016;38:E68-70.
    PubMed     Text format     Abstract available


  263. ORY M, Eran A
    Synchronous parotid and nasopharyngeal Warthin tumor.
    Head Neck. 2016;38:E71-2.
    PubMed     Text format     Abstract available


  264. NOEL D, Fink DS, Kunduk M, Schexnaildre MA, et al
    Secondary tracheoesophageal puncture using transnasal esophagoscopy in gastric pull-up reconstruction after total laryngopharyngoesophagectomy.
    Head Neck. 2016;38:E61-3.
    PubMed     Text format     Abstract available


  265. LETSOLO BT, Faust H, Ekblad L, Wennerberg J, et al
    Establishment and characterization of a human papillomavirus type 16-positive tonsillar carcinoma xenograft in BALB/c nude mice.
    Head Neck. 2016;38:417-25.
    PubMed     Text format     Abstract available


  266. DODD RH, Marlow LA, Waller J
    Discussing a diagnosis of human papillomavirus oropharyngeal cancer with patients: An exploratory qualitative study of health professionals.
    Head Neck. 2016;38:394-401.
    PubMed     Text format     Abstract available


  267. ZEVALLOS JP, Mitra N, Swisher-McClure S
    Patterns of care and perioperative outcomes in transoral endoscopic surgery for oropharyngeal squamous cell carcinoma.
    Head Neck. 2016;38:402-9.
    PubMed     Text format     Abstract available


    February 2016
  268. EDSON MA, Garden AS, Takiar V, Glisson BS, et al
    Outcomes for hypopharyngeal carcinoma treated with organ-preservation therapy.
    Head Neck. 2016 Feb 27. doi: 10.1002/hed.24387.
    PubMed     Text format     Abstract available


  269. XIONG J, Krishnaswamy G, Raynor S, Loh KS, et al
    Risk of swallowing-related chest infections in patients with nasopharyngeal carcinoma treated with definitive intensity-modulated radiotherapy.
    Head Neck. 2016 Feb 18. doi: 10.1002/hed.24296.
    PubMed     Text format     Abstract available


  270. KARATAS OF, Yuceturk B, Suer I, Yilmaz M, et al
    Role of miR-145 in human laryngeal squamous cell carcinoma.
    Head Neck. 2016;38:260-6.
    PubMed     Text format     Abstract available


  271. SPECTOR ME, Chinn SB, Bellile E, Gallagher KK, et al
    Matted nodes as a predictor of distant metastasis in advanced-stage III/IV oropharyngeal squamous cell carcinoma.
    Head Neck. 2016;38:184-90.
    PubMed     Text format     Abstract available


  272. MAZZONI E, Martini F, Corallini A, Taronna A, et al
    Serologic investigation of undifferentiated nasopharyngeal carcinoma and simian virus 40 infection.
    Head Neck. 2016;38:232-6.
    PubMed     Text format     Abstract available


  273. TOMIFUJI M, Araki K, Yamashita T, Mizokami D, et al
    Risk factors for dysphagia after transoral videolaryngoscopic surgery for laryngeal and pharyngeal cancer.
    Head Neck. 2016;38:196-201.
    PubMed     Text format     Abstract available


  274. CHUN BJ, Yoo IeR, Joo YH, Nam IC, et al
    Efficacy of 18F-fluorodeoxyglucose positron emission tomography/CT imaging for extracapsular spread of laryngeal squamous cell carcinoma.
    Head Neck. 2016;38:290-3.
    PubMed     Text format     Abstract available


  275. LIN H, Lin D, Xiong XS
    Roles of human papillomavirus infection and stathmin in the pathogenesis of sinonasal inverted papilloma.
    Head Neck. 2016;38:220-4.
    PubMed     Text format     Abstract available


  276. BUOHLIQA L, Upadhyay S, Nicolai P, Cavalieri R, et al
    Possible esthesioneuroblastoma metastasis to paranasal sinuses: Clinical report and literature review.
    Head Neck. 2016;38:E32-6.
    PubMed     Text format     Abstract available


  277. LIM SJ, Iyer NG, Ooi LL, Koong HN, et al
    Metastasectomy for metachronous pulmonary and hepatic metastases from nasopharyngeal carcinoma: Report of 6 cases and review of the literature.
    Head Neck. 2016;38:E37-40.
    PubMed     Text format     Abstract available


  278. CAMP S, Van Gerven L, Poorten VV, Nuyts S, et al
    Long-term follow-up of 123 patients with adenocarcinoma of the sinonasal tract treated with endoscopic resection and postoperative radiation therapy.
    Head Neck. 2016;38:294-300.
    PubMed     Text format     Abstract available


  279. RICH JT, Goldstein D, Haerle SK, Busato GM, et al
    Vascularized composite autograft for adult laryngotracheal stenosis and reconstruction.
    Head Neck. 2016;38:253-9.
    PubMed     Text format     Abstract available


  280. TIAN YM, Guan Y, Xiao WW, Zeng L, et al
    Long-term survival and late complications in intensity-modulated radiotherapy of locally recurrent T1 to T2 nasopharyngeal carcinoma.
    Head Neck. 2016;38:225-31.
    PubMed     Text format     Abstract available


  281. JOO YH, Cho KJ, Park JO, Nam IC, et al
    Swallowing function in patients with vertical hemipharyngolaryngectomy for hypopharyngeal squamous cell carcinoma.
    Head Neck. 2016;38:191-5.
    PubMed     Text format     Abstract available


  282. VENGALIL S, Giuliani ME, Huang SH, McNiven A, et al
    Clinical outcomes in patients with T4 laryngeal cancer treated with primary radiotherapy versus primary laryngectomy.
    Head Neck. 2016 Feb 1. doi: 10.1002/hed.24374.
    PubMed     Text format     Abstract available


    January 2016
  283. EVANS M, Powell N
    Reply to Letter to the Editor regarding "Sexual health in oral oncology: Breaking the news to patients with human papillomavirus-positive oropharyngeal cancer".
    Head Neck. 2016;38:157.
    PubMed     Text format    


  284. GRIFFITH RD, Simmons BJ, Falto-Aizpurua L, Nouri K, et al
    Letter to the Editor: Regarding HPV vaccination in patients who are infected with an oncogenic subtype.
    Head Neck. 2016;38:156.
    PubMed     Text format    


    December 2015
  285. LEWIS GD, Holliday EB, Kocak-Uzel E, Hernandez M, et al
    Intensity-modulated proton therapy for nasopharyngeal carcinoma: Decreased radiation dose to normal structures and encouraging clinical outcomes.
    Head Neck. 2015 Dec 26. doi: 10.1002/hed.24341.
    PubMed     Text format     Abstract available


  286. FLORIE M, Baijens L, Kremer B, Kross K, et al
    Relationship between swallow-specific quality of life and fiber-optic endoscopic evaluation of swallowing findings in patients with head and neck cancer.
    Head Neck. 2015 Dec 23. doi: 10.1002/hed.24333.
    PubMed     Text format     Abstract available


  287. OUYOUNG LM, Swanson MS, Villegas BC, Damodar D, et al
    ABCLOVE: Voice therapy outcomes for patients with head and neck cancer.
    Head Neck. 2015 Dec 22. doi: 10.1002/hed.24322.
    PubMed     Text format     Abstract available


  288. SENGAR M, Chorghe S, Jadhav K, Singh S, et al
    Cell-free Epstein-Barr virus-DNA in patients with nasopharyngeal carcinoma: Plasma versus urine.
    Head Neck. 2015 Dec 15. doi: 10.1002/hed.24297.
    PubMed     Text format     Abstract available


    November 2015
  289. DRIESSEN CM, Uijen MJ, van der Graaf WT, van Opstal CC, et al
    Degree of nephrotoxicity after intermediate- or high-dose cisplatin-based chemoradiotherapy in patients with locally advanced head and neck cancer.
    Head Neck. 2015 Nov 28. doi: 10.1002/hed.24281.
    PubMed     Text format     Abstract available


    August 2015
  290. TSAI MC, Shu YC, Hsu CC, Lin CK, et al
    False-positive finding of retropharyngeal lymph node recurrence in both fluorine FDG PET and MRI in a patient with nasopharyngeal carcinoma.
    Head Neck. 2015 Aug 28. doi: 10.1002/hed.24205.
    PubMed     Text format     Abstract available


  291. KHOR LK, Loi HY, Sinha AK, Tong KT, et al
    Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma.
    Head Neck. 2015 Aug 14. doi: 10.1002/hed.24164.
    PubMed     Text format     Abstract available


    December 2014
  292. NOEL CW, Foreman A, Goldstein DP, deAlmeida JR, et al
    Extent of neck dissection following transoral robotic surgical resection of oropharyngeal squamous cell carcinoma: A report of a case and potential indications for inclusion of level i in a selective neck dissection.
    Head Neck. 2014 Dec 9. doi: 10.1002/hed.23935.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Otorhinolaryngology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: